Citigroup Maintains Buy on DexCom, Lowers Price Target to $85

DexCom, Inc. +0.37%

DexCom, Inc.

DXCM

65.49

+0.37%

Citigroup analyst Joanne Wuensch maintains DexCom (NASDAQ: DXCM) with a Buy and lowers the price target from $105 to $85.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via